Newbond Holdings and Conversant Capital Close Acquisition of Two Major San Francisco Hotels — Neutral
HLT Business Wire — November 25, 2025NEW YORK--(BUSINESS WIRE)--A partnership between Newbond Holdings and Conversant Capital, which was formed to invest in large-format hospitality assets, today closed on the acquisition of two of San Francisco's largest and most recognizable hotels: the Hilton San Francisco Union Square and Parc 55 San Francisco – A Hilton Hotel. The combined purchase price for the two hotels, comprising approximately 3,000 rooms and representing roughly 10% of the city's total room inventory, was $408 million.
Xanadu, Rolls-Royce, and Riverlane unlock dramatic improvements for applications to jet engine airflow simulations using quantum computing — Neutral
CHAC GlobeNewsWire — November 25, 2025TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Xanadu, Rolls-Royce, and Riverlane have successfully completed their collaborative project on applications relevant to modeling jet engine airflow by utilizing quantum computing. By integrating Xanadu's PennyLane software and Riverlane's state-of-the-art quantum algorithms, the project enabled Rolls-Royce to achieve a reduction in simulation runtimes by orders of magnitude—shrinking calculation costs from weeks to less than an hour, unlocking new prototyping opportunities for the aerospace industry.
New survey finds Canadians believe credit card fine print is more confusing than taxes, medication labels, and furniture manuals — Neutral
AFRM Business Wire — November 25, 2025TORONTO--(BUSINESS WIRE)--Credit cards may be one of the most common ways Canadians pay for everyday expenses, but new research from Affirm (NASDAQ: AFRM) shows the terms and conditions behind them are among some of the most confusing everyday documents Canadians encounter. According to a national survey of 1,501 Canadians, only 41% ranked credit card terms and conditions among the top three easiest documents to understand, compared to 72% for medication labels, 69% for furniture assembly manua.
Companies Prioritize Revenue Performance with AI, ISG Says — Neutral
III Business Wire — November 25, 2025STAMFORD, Conn.--(BUSINESS WIRE)---- $III #ISGProviderLens--Companies are uniting revenue operations and performance management across channels, using software to align strategies with business goals, ISG says.
Portnoy Law Firm Announces Class Action on Behalf of WPP Plc.. Investors — Neutral
WPP GlobeNewsWire — November 25, 2025LOS ANGELES, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises WPP Plc, (“WPP” or the "Company") (NYSE: WPP) investors of a class action on behalf of investors that bought securities between February 27, 2025 and July 8, 2025, inclusive (the “Class Period”). WPP investors have until December 8, 2025 to file a lead plaintiff motion.
Portnoy Law Firm Announces Class Action on Behalf of Molina Healthcare, Inc. Investors — Neutral
MOH GlobeNewsWire — November 25, 2025LOS ANGELES, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Molina Healthcare, Inc., (“Molina” or the "Company") (NYSE: MOH) investors of a class action on behalf of investors that bought securities between February 5, 2025 and July 23, 2025, inclusive (the “Class Period”). Molina investors have until December 2, 2025 to file a lead plaintiff motion.
Rocky Mountain Chocolate Factory Announces Major Growth Surge with Commitments for 34 New Stores — Neutral
RMCF GlobeNewsWire — November 25, 2025Transformational strategy and focused brand refresh drive nearly 25% additional store growth and marks the strongest development period in Company history Transformational strategy and focused brand refresh drive nearly 25% additional store growth and marks the strongest development period in Company history
Portnoy Law Firm Announces Class Action on Behalf of aTyr Pharma, Inc. Investors — Neutral
ATYR GlobeNewsWire — November 25, 2025LOS ANGELES, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises aTyr Pharma, Inc., (“aTyr” or the "Company") (NASDAQ: ATYR) investors off a class action on behalf of investors that bought securities between January 16, 2025 and September 12, 2025, inclusive (the “Class Period”). aTyr investors have until December 8, 2025 to file a lead plaintiff motion.
CSX Chief Financial Officer and Chief Operating Officer to Address UBS Global Industrials and Transportation Conference — Neutral
CSX GlobeNewsWire — November 25, 2025JACKSONVILLE, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) Executive Vice President and Chief Financial Officer, Kevin Boone and Executive Vice President and Chief Operating Officer, Mike Cory, will address the 2025 UBS Global Industrials and Transportation Conference in Palm Beach on Tuesday, December 2, at 8:50 a.m. Eastern Time.
Medallion Financial Corp. to Participate at Two Upcoming Investor Conferences — Neutral
MFIN GlobeNewsWire — November 25, 2025Raymond James Small Cap Bank Conference on December 3 rd in New York City
Empire State Radiology Joins Cigna Network, Delivering Long-Term Access to Advanced Imaging for New Yorkers — Neutral
CI Business Wire — November 25, 2025NEW YORK--(BUSINESS WIRE)--Empire State Radiology, P.C. (ESR), a Radiology Partners-affiliated practice, announced a new, multi-year agreement with Cigna Health bringing ESR into Cigna's network of expanding participating providers beginning November 15, 2025. This new partnership strengthens network stability and enhances access for patients, hospitals, and referring physicians across New York ensuring Cigna's members have access to ESR's differentiated and subspecialized diagnostic and interv.
TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights — Neutral
TNDM GlobeNewsWire — November 24, 2025NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued materially misleading business information to the investing public.
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP — Neutral
INSP GlobeNewsWire — November 24, 2025NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline.
IVLU: Financials Probably Have A Little More To Run — Positive
IVLU Seeking Alpha — November 24, 2025Financials have performed very well already, particularly in Europe, but remain quite reasonably priced with NIMs rather resilient to rate cuts. In Japan, they are benefiting from greater investment and capital market activity. iShares Edge MSCI Intl Value Factor ETF has been a great way to avoid the major hit to portfolios from the significantly lower USD on a YTD basis.
Investors Rally Behind Alphabet Stock as Mark Benioff Endorses Gemini 3 — Neutral
GOOG GOOGL Investopedia — November 24, 2025Alphabet (GOOGL) stock has been on a tear. That run continued Monday.
‘Made in China?': House panel demands Amazon come clean on product origins — Negative
AMZN Fox Business — November 24, 2025House China Committee demands Amazon show country of origin for products before Black Friday. Company must respond by Dec. 15 on transparency reforms.
Tyson Foods to close major beef plant, scale back operations as cattle supplies decline — Negative
TSN Fox Business — November 24, 2025Tyson Foods will close its Nebraska beef plant affecting 3,200 workers and scale back Texas operations as cattle shortages force major industry restructuring.
Tonix: Maintaining Buy Rating With Potential Tonmya Expansion Indications — Positive
TNXP Seeking Alpha — November 24, 2025Tonix Pharmaceuticals Holding Corp. received FDA approval and launched Tonmya, the first new fibromyalgia drug in over 15 years. TNXP is expanding Tonmya into acute stress disorder [ASD] and major depressive disorder [MDD], with key phase 2 trials underway or planned to initiate. The company maintains a strong cash position, supporting operations into 2027, but future capital raises may be needed to commercialize Tonmya and fund the rest of the TNXP pipeline.
Inspire Medical (INSP) Sued Over Claims It Misled Investors on Next-Generation Device Launch -- Hagens Berman — Neutral
INSP GlobeNewsWire — November 24, 2025SAN FRANCISCO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Medical device manufacturer Inspire Medical Systems, Inc. (NYSE: INSP) is the subject of a securities class action lawsuit following a sharp decline in its stock price, with shareholders alleging the company misled investors about the launch of its latest product, the Inspire V device for obstructive sleep apnea.
Amazon to invest $15 billion in Indiana to boost data center infrastructure — Positive
AMZN Reuters — November 24, 2025Amazon.com is planning to invest about $15 billion in Northern Indiana to build data center campuses, the tech giant said as it looks to boost its cloud computing capacity to support booming artificial intelligence demand.